Bio
Terra Williams is a content scientist with a B.S. in Biological Engineering, and a minor in Biomedical Engineering from The Ohio State University. Before joining CAS, she gained industry experience in both toxicology and biomaterials at Victoria's Secret & Co.
Emerging Science
制药业能否战胜肥？
作为新型药物 Semaglutide（GLP-1 受体激动剂）的组成部分，探索 Ozempic、Wegovy 和 Mounjaro 如何通过调节血糖和食欲，帮助治疗肥胖症和糖尿病。
Read the CAS Insights article